|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14 Pt 1
|
|
pubmed:dateCreated |
2006-7-21
|
|
pubmed:abstractText |
Previously, we have synthesized and characterized a novel Cu(II) complex, copper N-(2-hydroxy acetophenone) glycinate (CuNG). Herein, we have determined the efficacy of CuNG in overcoming multidrug-resistant cancer using drug-resistant murine and human cancer cell lines.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:BaralRathindra NRN,
pubmed-author:BhattacharyyaSankarS,
pubmed-author:BiswasJaydipJ,
pubmed-author:ChoudhuriSoumitra KSK,
pubmed-author:DasTaniaT,
pubmed-author:DuttaPranabanandaP,
pubmed-author:EfferthThomasT,
pubmed-author:MajumderSurajitS,
pubmed-author:Mookerjee BasuJayatiJ,
pubmed-author:MookerjeeAnandaA,
pubmed-author:MukherjeePratimaP,
pubmed-author:PalSmarajitS,
pubmed-author:RahaSanghamitraS,
pubmed-author:RoyShyamalS,
pubmed-author:SaGourisankarG
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4339-49
|
|
pubmed:meshHeading |
pubmed-meshheading:16857809-Animals,
pubmed-meshheading:16857809-Antineoplastic Agents,
pubmed-meshheading:16857809-Apoptosis,
pubmed-meshheading:16857809-Carcinoma, Ehrlich Tumor,
pubmed-meshheading:16857809-Cell Line, Tumor,
pubmed-meshheading:16857809-Cell Proliferation,
pubmed-meshheading:16857809-Chelating Agents,
pubmed-meshheading:16857809-Copper,
pubmed-meshheading:16857809-Cytokines,
pubmed-meshheading:16857809-Doxorubicin,
pubmed-meshheading:16857809-Drug Resistance, Multiple,
pubmed-meshheading:16857809-Drug Resistance, Neoplasm,
pubmed-meshheading:16857809-Humans,
pubmed-meshheading:16857809-Leukocytes, Mononuclear,
pubmed-meshheading:16857809-Lymph Nodes,
pubmed-meshheading:16857809-Mice,
pubmed-meshheading:16857809-Neoplasm Transplantation,
pubmed-meshheading:16857809-Neoplasms,
pubmed-meshheading:16857809-Spleen
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
|
|
pubmed:affiliation |
Department of Environmental Carcinogenesis and Toxicology, Chittaranjan National Cancer Institute, India.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
